A Phase-1, Single Center, Double Blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Intravenous AZD9742 After Single Ascending Doses in Healthy Male and Female Subjects
Phase of Trial: Phase I
Latest Information Update: 01 Feb 2016
At a glance
- Drugs AZD 9742 (Primary)
- Indications Methicillin-resistant Staphylococcus aureus infections
- Focus Adverse reactions
- Sponsors AstraZeneca
- 17 Mar 2010 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 12 Feb 2010 New trial record.